Zetta Genomics Ltd is a biotechnology and life sciences startup based in the United Kingdom. Established in 2018, it aims to revolutionize healthcare through precision medicine by harnessing the potential of genomic data. The company's slogan, "The Genome Optimised Data Store: Enabling healthcare transformation using big data technology," reflects its commitment to leveraging advanced technology for the benefit of global health.
In its latest funding round on 08 February 2024, Zetta Genomics secured a significant investment of £1.80M. The investors involved in this Seed Round include Apex Ventures, Nina Ventures, We Venture Capital, and University of Cambridge Enterprise.
With its innovative approach to utilizing big data in the field of genomics, Zetta Genomics presents an intriguing opportunity for venture capitalists seeking to support groundbreaking technologies in the healthcare sector. Its potential to drive substantial advancements in precision medicine makes it a compelling prospect for investment within the life sciences industry.